These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36598935)

  • 1. Engineered Protein Copolymers for Heparin Neutralization and Detection.
    Liu Q; Shaukat A; Meng Z; Nummelin S; Tammelin T; Kontturi E; de Vries R; Kostiainen MA
    Biomacromolecules; 2023 Feb; 24(2):1014-1021. PubMed ID: 36598935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulfonated RAFT Copolymers as Heparin Mimetics: Synthesis, Reactivity Ratios, and Anticoagulant Activity.
    Nahain AA; Ignjatovic V; Monagle P; Tsanaktsidis J; Vamvounis G; Ferro V
    Macromol Biosci; 2020 Sep; 20(9):e2000110. PubMed ID: 32627962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin-binding copolymer reverses effects of unfractionated heparin, enoxaparin, and fondaparinux in rats and mice.
    Kalaska B; Kaminski K; Miklosz J; Yusa SI; Sokolowska E; Blazejczyk A; Wietrzyk J; Kasacka I; Szczubialka K; Pawlak D; Nowakowska M; Mogielnicki A
    Transl Res; 2016 Nov; 177():98-112.e10. PubMed ID: 27456749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin activates antithrombin anticoagulant function by generating new interaction sites (exosites) for blood clotting proteinases.
    Olson ST; Chuang YJ
    Trends Cardiovasc Med; 2002 Nov; 12(8):331-8. PubMed ID: 12536119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulant Heparin Mimetics via RAFT Polymerization.
    Nahain AA; Ignjatovic V; Monagle P; Tsanaktsidis J; Vamvounis G; Ferro V
    Biomacromolecules; 2020 Feb; 21(2):1009-1021. PubMed ID: 31841320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Luminescence Sensing of Biomacromolecules Heparin and Protamine in 100% Human Serum and Plasma by Supramolecular Polymeric Assemblies.
    Biswas R; Banerjee S
    Biomacromolecules; 2023 Feb; 24(2):766-774. PubMed ID: 36627763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coagulation protein function VI: augmentation of anticoagulant function by acetaldehyde-treated heparin.
    Brecher AS; Hellman K; Basista MH
    Dig Dis Sci; 1999 Jul; 44(7):1349-55. PubMed ID: 10489917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin supplement counteracts the prohemostatic effect of prothrombin complex concentrate and factor IX concentrate: An in vitro evaluation.
    Brinkman HJ; Patiwael S; Tripathi S; Meijers JC
    Thromb Res; 2016 Mar; 139():102-10. PubMed ID: 26916304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of hirudin versus heparin on hemocompatibility of blood contacting biomaterials: an in vitro study.
    Kopp R; Bernsberg R; Kashefi A; Mottaghy K; Rossaint R; Kuhlen R
    Int J Artif Organs; 2005 Dec; 28(12):1272-7. PubMed ID: 16404704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of unfractionated heparin and low molecular weight heparin on the clotting of platelet-reduced whole blood: an in-vitro study utilizing thromboelastography.
    Chung J; Stevic I; Gantioqui J; Atkinson H; Chan AKC; Chan HHW
    Blood Coagul Fibrinolysis; 2021 Jul; 32(5):305-311. PubMed ID: 34231501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of the anticoagulation regimen on endothelial-related coagulation in cardiac surgery patients.
    Boldt J; Schindler E; Welters I; Wittstock M; Stertmann WA; Hempelmann G
    Anaesthesia; 1995 Nov; 50(11):954-60. PubMed ID: 8678251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The significance of TFPI in clotting assays--comparison and combination with other anticoagulants.
    Nordfang O; Kristensen HI; Valentin S; Ostergaard P; Wadt J
    Thromb Haemost; 1993 Sep; 70(3):448-53. PubMed ID: 8259547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationally designed magnetic nanoparticles as anticoagulants for blood purification.
    Zhao W; Liu Q; Zhang X; Su B; Zhao C
    Colloids Surf B Biointerfaces; 2018 Apr; 164():316-323. PubMed ID: 29413611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin mimetics with anticoagulant activity.
    Nahain AA; Ignjatovic V; Monagle P; Tsanaktsidis J; Ferro V
    Med Res Rev; 2018 Sep; 38(5):1582-1613. PubMed ID: 29446104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Affinity-based design of a synthetic universal reversal agent for heparin anticoagulants.
    Shenoi RA; Kalathottukaren MT; Travers RJ; Lai BF; Creagh AL; Lange D; Yu K; Weinhart M; Chew BH; Du C; Brooks DE; Carter CJ; Morrissey JH; Haynes CA; Kizhakkedathu JN
    Sci Transl Med; 2014 Oct; 6(260):260ra150. PubMed ID: 25355700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Anticoagulant and Nonanticoagulant Properties of Heparin.
    Beurskens DMH; Huckriede JP; Schrijver R; Hemker HC; Reutelingsperger CP; Nicolaes GAF
    Thromb Haemost; 2020 Oct; 120(10):1371-1383. PubMed ID: 32820487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticoagulant synergism of heparin and activated protein C in vitro. Role of a novel anticoagulant mechanism of heparin, enhancement of inactivation of factor V by activated protein C.
    Petäjä J; Fernández JA; Gruber A; Griffin JH
    J Clin Invest; 1997 Jun; 99(11):2655-63. PubMed ID: 9169495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ROTEM monitoring of activated and non-activated prothrombin complex concentrate correction of dilutional coagulopathy.
    Elvstam O; Berntorp E; Schött U
    Scand J Clin Lab Invest; 2016; 76(3):202-7. PubMed ID: 26898225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assay-Based Differentiation in the Neutralization Profile of Unfractionated Heparin, Enoxaparin, and Fondaparinux by Andexanet Alfa.
    Siddiqui F; Tafur A; Bontekoe E; Iqbal O; Jeske W; Mehrotra S; Hoppensteadt D; Ramacciotti E; Fareed J
    Clin Appl Thromb Hemost; 2020; 26():1076029619895120. PubMed ID: 31914798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin affin regulatory peptide modulates the endogenous anticoagulant activity of heparin and heparan sulphate mimetics.
    Mejdoubi-Charef N; Courty J; Sineriz F; Papy-Garcia D; Charef S
    Basic Clin Pharmacol Toxicol; 2012 Nov; 111(5):296-302. PubMed ID: 22672269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.